Ophthalmic findings in postmenopausal Korean women with or without ERT.

The values represent the means ± SD or percentages (SE).The independent 2-sample t test was used for continuous variables and the χ2 test was used for categorical variables.ERT, estrogen replacement therapy.*As measured in the eye with the highest IOP value (the most affected eye); †Defined as more than 21 mmHg; ‡Defined as more than 0.5 in either the horizontal or vertical dimension; §Nuclear, cortical, posterior subcapsular, anterior polar, and mixed cataracts in individuals with the same type of opacity bilaterally; ≠Severe pterygia was defined as grade 2 and 3 pterygia; ΦDiabetic retinopathy was defined as the presence of 1 or more retinal microaneurysms or retinal blot hemorrhages with or without more severe lesions (hard exudate, soft exudate, intraretinal microvascular abnormalities, venous bleeding, neovascularization, or fibroglial proliferation).Ophthalmic findings in postmenopausal Korean women with or without ERT.本数据集中的数值以均值±标准差（standard deviation, SD）或百分比（标准误，standard error, SE）形式呈现。连续变量采用独立两样本t检验进行统计分析，分类变量则采用卡方（χ²）检验。本研究涉及雌激素替代疗法（estrogen replacement therapy, ERT）。*：以眼压（intraocular pressure, IOP）最高的眼睛（即受累最严重的眼）为测量对象；†：定义为眼压值大于21 mmHg；‡：定义为水平或垂直径线大于0.5；§：指双侧均存在同类型混浊的核性、皮质性、后囊下性、前极性白内障及混合性白内障患者；≠：重度翼状胬肉定义为2级和3级翼状胬肉；Φ：糖尿病视网膜病变定义为存在1个或以上视网膜微动脉瘤或视网膜斑片状出血，伴或不伴更严重病变（硬性渗出、软性渗出、视网膜内微血管异常、静脉出血、新生血管形成或纤维胶质增生）。本数据集收录了伴或不伴雌激素替代疗法的绝经后韩国女性的眼科检查结果。